What Is a Specialty Pharmacy Distribution Model?
A specialty pharmacy distribution model is the strategy a pharmaceutical manufacturer uses to determine which specialty pharmacies can dispense a specialty medication.
The model establishes how a product moves from manufacturer to patient and defines the level of control a manufacturer maintains over distribution, patient support services, and data reporting.
A specialty pharmacy distribution model defines the network of specialty pharmacies authorized to dispense a pharma manufacturer’s product. The chosen model affects patient access, provider experience, product visibility, adherence support, data collection, and overall commercial success.
How Do Pharmaceutical Manufacturers Select a Distribution Model?
Manufacturers typically select a distribution approach based on factors such as:
- Product complexity
- Disease state
- Patient population size
- Safety requirements
- Provider needs
- Market access considerations
- Regulatory requirements
The distribution model can significantly influence patient access, treatment adherence, and product performance after launch.
What Makes the Distribution of Specialty Products Different From Retail Medications?
Unlike traditional retail medications, specialty therapies often require:
- Complex handling and storage
- Patient education and support
- Prior authorization assistance
- Benefits investigation
- Adherence monitoring
- Ongoing clinical management
A well-designed specialty pharmacy network helps ensure patients receive appropriate support throughout their treatment journey.
What are the Main Three Types of Specialty Product Distribution Models?
Manufacturers generally choose from three primary distribution approaches:
- Open Distribution: In an open distribution model, a broad range of specialty pharmacies can dispense the product. This approach is often used for therapies with fewer handling complexities and larger patient populations.
- Limited Distribution Network (LDN): A limited distribution network restricts dispensing to a select group of specialty pharmacies, which enables greater control over how the product is handled. Under an LDN, manufacturers contract with a carefully specialty pharmacies that meet specific operational and clinical requirements. Many specialty products launch through an LDN because it allows manufacturers to closely monitor patient experiences and therapy initiation.
- Exclusive Distribution: An exclusive distribution model authorizes only one specialty pharmacy to dispense the medication. This model provides maximum control for the manufacturer, as well as centralized data collection, simplified operational oversight and coordinated patient management. Exclusive networks are often used for highly specialized therapies or treatments with complex clinical requirements.
How Does Specialty Pharmacy Distribution Affect Patient Access?
Distribution strategy plays a major role in the patient experience. The right specialty pharmacy network can help:
- Accelerate therapy initiation
- Reduce administrative burdens
- Improve benefits verification
- Facilitate prior authorization approvals
- Support patient education
- Increase adherence and persistence
However, overly restrictive networks can sometimes create challenges if providers or patients are unfamiliar with participating pharmacies.
